A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction
The DOI matches its Crossref record; 10 of the 11 references it cites were found in a registry or an index.
Abstract
The global endemic of cardiovascular diseases calls for improved risk assessment and treatment. Here, we describe an association between myocardial infarction (MI) and a common sequence variant on chromosome 9p21. This study included a total of 4587 cases and 12,767 controls. The identified variant, adjacent to the tumor suppressor genes CDKN2A and CDKN2B , was associated with the disease with high significance. Approximately 21% of individuals in the population are homozygous for this variant, and their estimated risk of suffering myocardial infarction is 1.64 times as great as that of noncarriers. The corresponding risk is 2.02 times as great for early-onset cases. The population attributable risk is 21% for MI in general and 31% for early-onset cases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and has also been robustly associated with CHD outcomes.(40-42)”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [41]
In the citing paper
“Additionally, endometriosis and CHD may share common genetic susceptibilities.”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [41]
In the citing paper
“Since 2007, genomewide association analyses have identified more than 50 independent loci associated with the risk of coronary artery disease.7–15”
From Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease (2016) · cites this paper as [8]
In the citing paper
“Interestingly, atherosclerotic plaques from patients carrying a genetic variation at the 9p21 locus (which includes the CDKN2B gene), which has been associated with atherosclerosis in humans204,205, have reduced levels of calreticulin compared with atherosclerotic plaques from non-carriers203, further supporting a role for defective efferocytosis in cardiovascular disease206.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [204]
In the citing paper
“Examples include the region at 8q24 associated with prostate, breast, and colon cancer, 300 kb from the nearest gene (103, 104), and the region at 9q21 associated with myocardial infarction and T2D, 150 kb from the nearest genes encoding CDKN2A and CDKN2B (99–101, 105–107).”
From Genetic Mapping in Human Disease (2008) · cites this paper as [107]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
Genomic Control for Association Studies
Devlin, B., & Roeder, K. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00997.x · Cited by 3,162
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009
Vascular Cell Senescence: Contribution to Atherosclerosis
Minamino, T., & Komuro, I. (2007) · Circulation Research · doi:10.1161/01.res.0000256837.40544.4a · Cited by 542
Heritability of death from coronary heart disease: a 36‐year follow‐up of 20 966 Swedish twins
Zdravkovic, S., Wienke, A., Pedersen, N. L., Marenberg, M. E., Yashin, A. I., & De Faire, U. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01029.x · Cited by 511
Wang, Q., Rao, S., Shen, G.-Q., Li, L., Moliterno, D. J., Newby, L. K., Rogers, W. J., Cannata, R., Zirzow, E., Elston, R. C., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/381560 · Cited by 217
Samani, N. J. (2005) · The American Journal of Human Genetics · doi:10.1086/498653 · Cited by 126
Zintzaras, E., & Kitsios, G. D. (2006) · Journal of Human Genetics · doi:10.1007/s10038-006-0053-x · Cited by 24
Research works printed but not linked: 2
- T. Thom et al., Circulation113, e85 (2006).
- N. Mantel, W. Haenszel, J. Natl. Cancer Inst.22, 719 (1959).
Cited by
Items 601–700 of 1,001
Willows: a memory efficient tree and forest construction package
Zhang, H., Wang, M., & Chen, X. '. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-130 · Cited by 36
Rieder, M. J., Livingston, R. J., Stanaway, I. B., & Nickerson, D. A. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530801952880 · Cited by 34
Tyrosine Hydroxylase Gene: Another Piece of the Genetic Puzzle of Parkinson’s Disease
Bademci, G., Vance, J. M., & Wang, L. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800792866 · Cited by 36
Patel, R. S., Schmidt, A. F., Tragante, V., McCubrey, R. O., Holmes, M. V., Howe, L. J., Direk, K., Åkerblom, A., Leander, K., Virani, S. S., et al. (2019) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.119.002471 · Cited by 37
“8 We found that: (1) in contrast to the known strong association with CHD observed in CARDIoGRAMPlusC4D, there was a markedly attenuated and non-significant association with subsequent CHD events in GENIUS-CHD; (2) effect estimates in GENIUSCHD were broadly consistent in stratified analyses based on features related t…”
Genomics and Cardiovascular Drug Development
Plump, A. S., & Lum, P. Y. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.050 · Cited by 31
Efecto aditivo de diferentes variantes genéticas en el riesgo de cardiopatía isquémica
Lluís-Ganella, C., Lucas, G., Subirana, I., Sentí, M., Jiménez-Conde, J., Marrugat, J., Tomás, M., & Elosúa, R. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70204-9 · Cited by 33
SNPs on chromosome 5p15.3 associated with myocardial infarction in Japanese population
Aoki, A., Ozaki, K., Sato, H., Takahashi, A., Kubo, M., Sakata, Y., Onouchi, Y., Kawaguchi, T., Lin, T., Takano, H., et al. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.141 · Cited by 37
Hoppmann, P., Erl, A., Türk, S., Tiroch, K. A., Mehilli, J., Schömig, A., Kastrati, A., & Koch, W. (2009) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2009.08.021 · Cited by 31
Jansen, H., Loley, C., Lieb, W., Pencina, M. J., Nelson, C. P., Kathiresan, S., Peloso, G. M., Voight, B. F., Reilly, M. P., Assimes, T. L., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.033 · Cited by 33
Self-citationAre Genetic Tests for Atherosclerosis Ready for Routine Clinical Use?
Paynter, N. P., Ridker, P. M., & Chasman, D. I. (2016) · Circulation Research · doi:10.1161/circresaha.115.306360 · Cited by 36
Wung, S., Hickey, K. T., Taylor, J. Y., & Gallek, M. J. (2013) · Journal of Nursing Scholarship · doi:10.1111/jnu.12002 · Cited by 34
Lai, H., Li, X., Yang, Y., Ma, Y., Xu, R., Pan, S., Zhai, H., Liu, F., Chen, B., & Zhao, Q. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129144 · Cited by 31
de Sousa, A. G. P., Selvatici, L. S., Krieger, J. E., & Pereira, A. C. (2011) · The Review of Diabetic Studies · doi:10.1900/rds.2011.8.230 · Cited by 35
Klemke, F., Baier, A., Knoop, H., Kern, R., Jablonský, J., Beyer, G., Volkmer, T., Steuer, R., Lockau, W., & Hagemann, M. (2015) · Microbiology · doi:10.1099/mic.0.000055 · Cited by 31
“Interestingly, the Sll1559 protein showed sequence similarities to biochemically verified PSTAs, including the enzymes of E. coli (Duncan & Coggins, 1986), A. thaliana (Ho et al., 1998), B. circulans (Battchikova et al., 1996) and two Archaea (Helgadottir et al., 2007).”
BackgroundDimasi, D. P., Burdon, K. P., Hewitt, A. W., Fitzgerald, J., Wang, J. J., Healey, P. R., Mitchell, P., Mackey, D. A., & Craig, J. E. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.04.023 · Cited by 32
The Enigma of Genetics Etiology of Atherosclerosis in the Post-GWAS Era
Marian, A. J. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0245-0 · Cited by 34
Hägg, D. A., Jernås, M., Wiklund, O., Thelle, D. S., Fagerberg, B., Eriksson, P. O., Hamsten, A., Olsson, B., Carlsson, B., Carlsson, L. M. S., et al. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.21.6.697 · Cited by 32
Dehghan, A., van Hoek, M., Sijbrands, E. J. G., Oostra, B. A., Albert Hofman, D., van Duijn, C. M., & Witteman, J. C. M. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-30 · Cited by 31
Non-Coding RNAs and Lipid Metabolism
Smolle, E., & Haybaeck, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150813494 · Cited by 32
Evaluation of Nanofluidics Technology for High-Throughput SNP Genotyping in a Clinical Setting
Chan, M., Chan, M. W., Loh, T. W., Law, H. Y., Yoon, C. S., Than, S. S., Chua, J. M., Wong, C. Y., Yong, W. S., Yap, Y. S., et al. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.12.001 · Cited by 30
Virani, S. S., Brautbar, A., Lee, V., Elayda, M. A., Morrison, A. C., Grove, M. L., Nambi, V., Frazier, L. Q., Wilson, J. M., Willerson, J. T., et al. (2012) · Circulation Journal · doi:10.1253/circj.cj-11-1166 · Cited by 31
Fan, M., Dandona, S., McPherson, R., Allayee, H., Hazen, S. L., Wells, G. A., Roberts, R., & Stewart, A. F. R. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000104 · Cited by 30
The function of long non-coding RNAs in vascular biology and disease
Kok, F. O., & Baker, A. H. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2018.06.004 · Cited by 30
Self-citationAnderson, J. L., Horne, B. D., Camp, N. J., Muhlestein, J. B., Hopkins, P. N., Cannon‐Albright, L., Mower, C. P., Park, J. J., Clarke, J., Nicholas, Z. P., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.05.031 · Cited by 34
Randomized Trial of Personal Genomics for Preventive Cardiology: Design and Challenges
Knowles, J. W., Assimes, T. L., Kiernan, M., Pavlović, A., Goldstein, B. A., Yank, V. A., McConnell, M. V., Absher, D., Bustamante, C. D., Ashley, E. A., et al. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.112.962746 · Cited by 34
Genetics Education for Health Professionals: A Context
McInerney, J. D. (2007) · Journal of Genetic Counseling · doi:10.1007/s10897-007-9126-z · Cited by 30
“However, with the rapid pace of change in genetic medicine, specific content will fall short of what PCPs really need....A thoughtful, deliberate, and informed refinement of the ‘usual’ cognitive strategies will have the greatest impact on integrating genetics into all of health care ( Hayflick and Eiff 2002 ).”
BackgroundCommon Variants in the Periostin Gene Influence Development of Atherosclerosis in Young Persons
Hixson, J. E., Shimmin, L. C., Montasser, M. E., Kim, D., Zhong, Y., Ibarguen, H. P., Follis, J. L., Malcom, G. T., Strong, J. P., Howard, T. D., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.224352 · Cited by 33
Kiechl, S. J., Laxton, R. C., Xiao, Q., Hernesniemi, J. A., Raitakari, O. T., Kähönen, M. A. P., Mayosi, B. M., Jula, A., Moilanen, L., Willeit, J., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213785 · Cited by 30
Polygenic Risk Scores in Coronary Artery Disease and Atrial Fibrillation
Gladding, P. A., Legget, M. E., Fatkin, D., Larsen, P., & Doughty, R. N. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.12.004 · Cited by 35
Seidelmann, S. B., Kuo, C.-L., Pleskac, N., Molina, J., Sayers, S., Li, R., Zhou, J., Johnson, P. Y., Braun, K. R., Chan, C. K., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.176800 · Cited by 34
Genetics meets epigenetics: Genetic variants that modulate noncoding RNA in cardiovascular diseases
Calore, M., Windt, L. J. D., & Rampazzo, A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.10.028 · Cited by 34
Severance, L. M., Contijoch, F. J., Carter, H. K., Fan, C. C., Seibert, T. M., Dale, A. M., & McVeigh, E. R. (2019) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2019.05.005 · Cited by 29
Atherosclerosis and Inflammatory Bowel Disease—Shared Pathogenesis and Implications for Treatment
Kamperidis, N., Kamperidis, V., Zegkos, T., Kostourou, I., Nikolaidou, O., Arebi, N., & Karvounis, H. I. (2020) · Angiology · doi:10.1177/0003319720974552 · Cited by 33
“Vitamin D has emerged as a key environmental factor in the pathogenesis of IBD: A study among nurses in the United States confirmed that living in a Southern state where sunlight hours are longer is a factor protecting from IBD, possibly because of the higher vitamin D levels related to sunlight exposure.81 Moreover a…”
BackgroundInfluentialKertai, M. D., Mosley, J. D., He, J., Ramakrishnan, A., Abdelmalak, M., Hong, Y., Shoemaker, M. B., Roden, D. M., & Bastarache, L. A. (2021) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.120.003269 · Cited by 32
Biomarkers and their Consequences for the Biomedical Profession: A Social Science Perspective
Metzler, I. (2010) · Personalized Medicine · doi:10.2217/pme.10.41 · Cited by 32
Genetics of Coronary Artery Disease in the 21st Century
Roberts, R., & Stewart, A. F. R. (2012) · Clinical Cardiology · doi:10.1002/clc.22002 · Cited by 33
Association between genetic variation on chromosome 9p21 and aneurysmal subarachnoid haemorrhage
Olsson, S., Csajbok, L. Z., Jood, K., Nylén, K., Nellgård, B., & Jern, C. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.187427 · Cited by 29
Prognostic Value of Plasma Long Noncoding RNA ANRIL for In-Stent Restenosis
Wang, F., Su, X., Liu, C., Wu, M., & Li, B. (2017) · Medical Science Monitor · doi:10.12659/msm.904352 · Cited by 29
What Causes Premature Coronary Artery Disease?
Le, A., Peng, H., Golinsky, D., Scipio, M. D., Lali, R., & Paré, G. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01200-y · Cited by 38
“Homozygous carriers of the 9p21 variant have an approximate two-fold greater risk of disease within pCAD populations [106].”
Genetic analysis of the 9p21.3 CAD risk locus in Asian Indians
Arvind, P., Jambunathan, S., Nair, J., Kakkar, V. V., & Shanker, J. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-08-0706 · Cited by 28
Kim, Y., Suktitipat, B., Yanek, L. R., Faraday, N. R., Wilson, A. F., Becker, D. M., Becker, L. C., & Mathias, R. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064179 · Cited by 33
“We retained the 235 sequence variants identified with Sanger sequencing and all104 subjects for subsequent statistical analyses; this includes nine additional variants called in the completed dataset compared to 226 presented earlier [11].”
MethodБарсова, Р. М., Lvovs, D., Titov, B. V., Matveeva, N. A., Shakhnovich, R. M., Sukhinina, T. S., Kukava, N. G., Ruda, M. Y., Карамова, И. М., Насибуллин, Т. Р., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144190 · Cited by 29
Genetic Association at the 9p21 Glaucoma Locus Contributes to Sex Bias in Normal-Tension Glaucoma
Ng, S. K., Burdon, K. P., Fitzgerald, J., Zhou, T., Fogarty, R. A., Souzeau, E., Landers, J. A., Mills, R. A., Casson, R. J., Ridge, B., et al. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19401 · Cited by 28
Li, Y., Wang, H., & Zhang, Y.-Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16849 · Cited by 27
Post-GWAS functional analysis identifies CUX1 as a regulator of p16INK4a and cellular senescence
Jiang, D., Sun, W., Wu, T., Zou, M., Vasamsetti, S. B., Zhang, X., Zhao, Y., Phillippi, J. A., Sawalha, A. H., Tavakoli, S., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00177-0 · Cited by 31
“(1) SNP track showing locations of the 24 candidate fSNPs; (2–4) three epigenetic tracks for H3K27ac, H3K4me1 and H3K4me3, known as transcriptional factor-binding sites; (5) DNase I hypersensitivity sites (DNase I HS) in human astrocytes; (6) predicted regulatory elements including promoters (red) and enhancers (gray)…”
BackgroundMinear, M. A., Crosslin, D. R., Sutton, B. S., Connelly, J. J., Nelson, S. C., Gadson, S., Wang, T., Seo, D., Vance, J. M., Sketch, M. H., et al. (2011) · Human Genetics · doi:10.1007/s00439-011-0959-z · Cited by 30
“3 has been consistently associated with common, complex CAD in multiple datasets (Helgadottir et al. 2007; McPherson et al. 2007; Wellcome Trust Case Control Consortium, 2007; Samani et al. 2007), but like the Mendelian variants this locus is also thought to account for only a fraction of total CAD…”
BackgroundSelf-citationPreliminary Evidence of a Genetic Association Between Chromosome 9p21.3 and Human Longevity
Emanuele, E., Fontana, J. M., Minoretti, P., & Geroldi, D. (2010) · Rejuvenation Research · doi:10.1089/rej.2009.0970 · Cited by 28
Heckman, M. G., Soto‐Ortolaza, A. I., Diehl, N. N., Rayaprolu, S., Brott, T. G., Wszołek, Z. K., Meschia, J. F., & Ross, O. A. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03846.x · Cited by 29
Rivera, N. V., Carreras‐Torres, R., Roncarati, R., Anselmi, C. V., Micco, F. D., Mezzelani, A., Koch, W., Hoppmann, P., Kastrati, A., Stewart, A. F. R., et al. (2013) · BMC Medical Genetics · doi:10.1186/1471-2350-14-11 · Cited by 30
Carty, C. L., Bůžková, P., Fornage, M., Franceschini, N., Cole, S. A., HEISS, G. M., Hindorff, L. A., Howard, B. V., Mann, S., Martin, L. W., et al. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.962191 · Cited by 28
Genetic Risk Scores Predict Recurrence of Acute Coronary Syndrome
Vaara, S. M., Tikkanen, E., Parkkonen, O., Lokki, M., Ripatti, S., Perola, M., Nieminen, M. S., & Sinisalo, J. P. (2016) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.115.001271 · Cited by 30
Genome-wide association scans for Type 2 diabetes: new insights into biology and therapy
McCarthy, M. I., & Zeggini, E. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.008 · Cited by 31
Genetic Epidemiology in Aging Research
Fallin, M. D., & Matteini, A. M. (2009) · The Journals of Gerontology Series A · doi:10.1093/gerona/gln021 · Cited by 32
Incident coronary artery calcium among postmenopausal women
Kuller, L. H., Matthews, K. A., Edmundowicz, D., & Chang, Y. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.057 · Cited by 29
Scanning the Genome for Coronary Risk
Rosenzweig, A. (2007) · New England Journal of Medicine · doi:10.1056/nejme078121 · Cited by 28
Monogenic and Polygenic Models of Coronary Artery Disease
Muse, E. D., Chen, S.-F., & Torkamani, A. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01540-0 · Cited by 27
Zhang, L., Bůžková, P., Wassel, C. L., Roman, M. J., North, K. E., Crawford, D. C., Boston, J., Brown-Gentry, K. D., Cole, S. A., Deelman, E., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.02.038 · Cited by 29
“1) [18], rs10757278 (9p21) [13], rs1333049 (9p21) [12,14], rs2383206 (9p21) [17], rs2383207 (9p21) [13], rs17228212 (SMAD3) [14], and rs2549513 (16q23.”
Peroxisome Proliferator‐Activated Receptor Gamma Polymorphisms and Coronary Heart Disease
Dallongeville, J., Iribarren, C., Ferrières, J., Lyon, L. L., Evans, A., Go, A. S., Arveiler, D., Fortmann, S. P., Ducimetière, P., Hlatky, M. A., et al. (2009) · PPAR Research · doi:10.1155/2009/543746 · Cited by 30
Towards a Molecular Systems Model of Coronary Artery Disease
Abraham, G., Bhalala, O. G., de Bakker, P. I. W., Ripatti, S., & Inouye, M. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0488-1 · Cited by 31
Genome-Wide Association Studies of Coronary Artery Disease: Recent Progress and Challenges Ahead
Clarke, S. L., & Assimes, T. L. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0748-4 · Cited by 28
How Will Genetics Inform the Clinical Care of Atrial Fibrillation?
Shoemaker, M. B., Shah, R. L., Roden, D. M., & Perez, M. V. (2020) · Circulation Research · doi:10.1161/circresaha.120.316365 · Cited by 27
Severance, L. M., Carter, H. K., Contijoch, F. J., & McVeigh, E. R. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.11.013 · Cited by 28
Severino, P., D’Amato, A., Prosperi, S., Myftari, V., Colombo, L., Tomarelli, E., Piccialuti, A., Pietro, G. D., Birtolo, L. I., Maestrini, V., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103586 · Cited by 35
Three SNPs on chromosome 9p21 confer increased risk of myocardial infarction in Chinese subjects
Zhang, Q., Wang, X., Cheng, S., Wan, X., Cao, F., Li, L., Chen, X., Liu, W., Yang, X., & Li, J. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.017 · Cited by 27
Bacci, S., Prudente, S., Copetti, M., Spoto, B., Rizza, S., Baratta, R., Pietro, N. D., Morini, E., Paola, R. D., Testa, A., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.10.035 · Cited by 31
High-throughput sequencing of microdissected chromosomal regions
Weise, A., Timmermann, B., Grabherr, M. G., Werber, M., Heyn, P. C., Kosyakova, N., Liehr, T., Neitzel, H., Konrat, K., Bommer, C., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.196 · Cited by 27
GISSI Prevenzione Investigators and SIBioC-GISSI Prevenzione Group, Gori, F., Specchia, C., Pietri, S. D., Crociati, L., Barlera, S., Franciosi, M., Nicolucci, A., Signorini, S. G., Brambilla, P., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-60 · Cited by 26
Genetic Insights Into Frailty: Association of 9p21-23 Locus With Frailty
Sathyan, S., Barzilai, N., Atzmon, G., Milman, S., Ayers, E. I., & Verghese, J. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00105 · Cited by 32
Genome-wide association studies in atherothrombosis
Lotta, L. A. (2009) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2009.11.003 · Cited by 28
“Seven GWAS have addressed the relationship between MI and common genetic variants (or its major determinant, coronary artery disease, CAD) [28,30–35] (Table 1).”
BackgroundJónasson, F. (2009) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2009.01635.x · Cited by 32
“Further details regarding these cases and controls can be found in recent publications (Helgadottir et al. 2007, 2008).”
BackgroundLiu, X., Wang, X., Shen, Y., Wu, L., Ruan, X., Lindpaintner, K., Yusuf, S., Engert, J. C., Anand, S. S., Tan, X., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.02.004 · Cited by 27
“[3] Helgadottir A, Thorleifsson G, Manolescu A, et al.”
BackgroundPatel, R. S., & Ye, S. (2011) · Heart · doi:10.1136/hrt.2010.219675 · Cited by 34
Primary Open-Angle Glaucoma Genetics in African Americans
RESTREPO, N. A., & Bailey, J. N. C. (2017) · Current Genetic Medicine Reports · doi:10.1007/s40142-017-0131-8 · Cited by 28
Hueso, M., Cruzado, J. M., Torrás, J., & Navarro, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061734 · Cited by 30
“On a genomic level, the 9p21 risk locus is a protein-coding gene-free region, encoding a long noncoding RNA (lncRNA) called ANRIL/CDKN2B-AS1 (antisense noncoding RNA in the INK4 locus, or CDKN2B antisense 1), which was identified as a genetic factor associated with cardiovascular morbidity and mortality [114], also co…”
BackgroundTirdea, C., Hostiuc, S., Moldovan, H., & Scafa‐Udriște, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315008 · Cited by 27
“For MI in general, the population attributable risk is 21%, and for early-onset instances, it is 31% [32].”
BackgroundA common variant in chromosome 9p21 associated with coronary artery disease in Asian Indians
Maitra, A., Dash, D., John, S., Sannappa, P. R., Das, A. P., Shanker, J., Rao, V., Sridhara, H., & Kakkar, V. V. (2009) · Journal of Genetics · doi:10.1007/s12041-009-0017-y · Cited by 26
Common genetic polymorphisms in Moyamoya and atherosclerotic disease in Europeans
Roder, C., Peters, V., Kasuya, H., Nishizawa, T., Takehara, Y., Berg, D., Schulte, C., Khan, N., Tatagiba, M. S., & Krischek, B. (2010) · Child s Nervous System · doi:10.1007/s00381-010-1241-8 · Cited by 28
Johnson, C. Y., Tuite, A. R., Morange, P., Trégouët, D., & Gagnon, F. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq349 · Cited by 29
From candidate gene to genome-wide association studies in cardiovascular disease
Gianfagna, F., Cugino, D., Santimone, I., & Iacoviello, L. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.11.014 · Cited by 26
“However, the first genome-wide association studies on cardiovascular diseases using SNPs selected on the basis of linkage disequilibrium were published in 2007 [13–16].”
BackgroundLai, C., Chen, Y.-T., Gu, J. H., Nerbonne, J. M., Lin, C., & Yang, K. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.08.013 · Cited by 28
Meletiadis, J., Chanock, S. J., & Walsh, T. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.5.561 · Cited by 27
Aherrahrou, R., Reinberger, T., Hashmi, S., & Erdmann, J. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae161 · Cited by 25
Cheng, Y.-C., Anderson, C. D., Bione, S., Keene, K. L., Maguire, J. M., Nalls, M. A., Rasheed, A., Zeginigg, M., Attia, J. R., Baker, R. I., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.632075 · Cited by 27
Nolan, D. K., Sutton, B. S., Haynes, C. S., Johnson, J., Sebek, J., Dowdy, E., Crosslin, D. R., Crossman, D. C., Sketch, M. H., Granger, C. B., et al. (2012) · BMC Genetics · doi:10.1186/1471-2156-13-12 · Cited by 27
Self-citationDyslipidemia in HIV-Infected Individuals: from Pharmacogenetics to Pharmacogenomics
TARR, P. E., Rotger, M., & Telenti, A. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.35 · Cited by 27
Overexpression of CDKN2B is involved in poor gastric cancer prognosis
Chen, X., Yu, X., & Shen, E. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29287 · Cited by 25
“Previously, CDKN2B was considered as a candidate gene in coronary heart disease (CHD).(13-15) CDKN2B knockdown accelerated further development of atherosclerotic plaques, indicating a substantial function of CDKN2B in CHD progression as well as development.”
BackgroundYuan, H., Tsai, T., Wang, H.-P., Chien, Y.-S., Chen, C., Chu, C., Ho, C.-T., Chu, P., & Chen, C.-F. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.128131 · Cited by 25
Molecular genetics of primary open-angle glaucoma
Yadav, M. K., Bhardwaj, A., Yadav, A. K., Dada, R., & Tanwar, M. (2023) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_2570_22 · Cited by 32
“[65] Many diseases, including cardiovascular disease,[146] diabetes,[147] intracranial aneurysms,[148] and gliomas[149] are associated with CDKN2B‐AS1 SNPs.”
BackgroundThe cis and trans effects of the risk variants of coronary artery disease in the Chr9p21 region
Zhao, W., Smith, J. A., Mao, G., Fornage, M., Peyser, P. A., Sun, Y. V., Turner, S. T., & Kardia, S. L. R. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0094-0 · Cited by 25
Genome‐Wide Association Study of Coronary Artery Disease
Ogawa, N., Imai, Y., Morita, H., & Nagai, R. (2010) · International Journal of Hypertension · doi:10.4061/2010/790539 · Cited by 28
Ference, B. A., Yoo, W., Flack, J. M., & Clarke, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028834 · Cited by 28
Tayebi, N., Ke, T., Foo, J. N., Friedlander, Y., Liu, J., & Heng, C. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.01.004 · Cited by 26
Hamrefors, V., Hedblad, B., Hindy, G., Smith, J. G., Almgren, P., Engström, G., Sjögren, M., Gränsbo, K., Orho‐Melander, M., & Melander, O. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085893 · Cited by 30
Peng, W. H., Lu, L., Zhang, Q., Zhang, R., Wang, L. J., Yan, X. X., Chen, Q., & Shen, W. F. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.215 · Cited by 25
Advancing Cardiovascular Research
Lauer, M. S. (2012) · CHEST Journal · doi:10.1378/chest.11-2521 · Cited by 29
The chromosome 9p21 region and myocardial infarction in a European population
Koch, W., Türk, S., Erl, A., Hoppmann, P., Pfeufer, A., King, L. A., Schömig, A., & Kastrati, A. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.014 · Cited by 26
Comprehensive analysis of LAMC1 genetic variants in advanced pelvic organ prolapse
Wu, J. M., Visco, A. G., Grass, E. A., Craig, D. M., Fulton, R. G., Haynes, C. S., Amundsen, C. L., & Shah, S. H. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.01.033 · Cited by 25
Self-citationÄrlestig, L., & Rantapää‐Dahlqvist, S. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111336 · Cited by 26
Genomics in cardiac metabolism
Samuel, J., SCHAUB, M. C., Zaugg, M., Mamas, M. A., Dunn, W. B., & Swynghedauw, B. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn061 · Cited by 37
Lin, J. J., & Musunuru, K. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.117.001946 · Cited by 28
Metadata
- Authors
- Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., Jonasdottir, A., Sigurdsson, A., Baker, A., Palsson, A., Masson, G., Gudbjartsson, D. F., Magnusson, K. P., Andersen, K., Levey, A. I., Backman, V. M., Matthiasdottir, S., Jonsdottir, T., Palsson, S., Einarsdottir, H., Gunnarsdottir, S., Gylfason, A., Vaccarino, V., Hooper, W. C., Reilly, M. P., Granger, C. B., Austin, H., Rader, D. J., Shah, S. H., Quyyumi, A. A., Gulcher, J. R., Thorgeirsson, G., Thorsteinsdottir, U., Kong, A., & Stefansson, K.
- Affiliations
- deCODE genetics, Sturlugata 8, IS-101 Reykjavik, Iceland.
- deCODE Genetics (Iceland) (IS)
- Corresponding author
- Manolescu, Andrei
- Kong, Augustine
- ORCID
- Venue
- Science
- Published
- 2007-06-08
- Volume
- 316
- Issue
- 5830
- Pages
- 1491-1493
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2036198235
- Semantic Scholar
- c6c5bbe025441bb878530bbd85db55cb110ef15a
- Cited by
- 1,594
- References
- 11
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 25 · 2023: 30 · 2022: 28 · 2021: 56 · 2020: 39 · 2019: 60 · 2018: 80 · 2017: 71 · 2016: 71 · 2015: 87 · 2014: 97 · 2013: 92 · 2012: 130
- FWCI
- 98.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- myocardial infarction, chromosome 9p21, genetic susceptibility, CDKN2A, CDKN2B, tumor suppressor, single nucleotide polymorphisms, early-onset myocardial infarction, population attributable risk, cardiovascular risk
- MeSH terms
- Aged, Chromosome Mapping, Chromosomes, Human, Pair 9, Coronary Artery Disease, Female, Genotype, Haplotypes, Heterozygote, Homozygote, Humans, Male, Middle Aged, Myocardial Infarction, Risk Factors, Genetic Variation, Linkage Disequilibrium, Case-Control Studies, Age of Onset, Genes, p16, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.